Skip to main content
  1. Home
  2. Emerging Tech
  3. Health & Fitness
  4. News

Gel-based 'male birth control' could enable temporary, reversible vasectomies

Add as a preferred source on Google

Vasectomies are a great thing, but while people may be sure that they’re the right decision to take at the time, it’s difficult to know exactly what the future will hold.

True, there are vasectomy reversal operations, but these have a decreasing chance of leading to a successful pregnancy the longer they are left after the operation. Ten years after a vasectomy is carried out, a reversed operation will lead to pregnancy only around 30 percent of the time.

Recommended Videos

Things may be looking up, however, thanks to a new vasectomy alternative recently described in the journal Basic and Clinical Andrology. It involves a substance called Vasalgel, which doesn’t impair the manufacture or swimming of sperm, but instead stops it from reaching its, erm, point of release.

“In a regular vasectomy, an incision is made on each side of the scrotum and surgeons then severe the vas deferens, referring to the long tube which winds around from the testicle to the penis, carrying sperm to where it enters the semen,” Professor Catherine VandeVoort, one of the co-authors on the paper, told Digital Trends. “There are various approaches to a vasectomy, but they involve destroying the integrity of the vas: either removing a piece, crushing it with a clamp mechanism, or cutting and cauterizing it.”

In the new alternative method, instead of crushing or cauterizing the vas, the Vasalgel is injected under anesthetic, which then acts as a barrier, preventing the sperm from going any further.

“The advantage to this is that the integrity of the vas can be maintained, which means that at a later date you could potentially go back and flush this gel out without problem,” VandeVoort continued.

So far, the injection part of the procedure has been tested by University of California researchers on a group of 16 adult male monkeys, with more than half the group already being fathers. The monkeys were observed for a week following the injection, after which they were allowed to rejoin the fertile females from their group. Despite mating taking place, none of the female monkeys became impregnated.

According to VandeVoort, a clinical trial with (human) males is planned as a future step, although even if this is successful, it is likely that a publicly-available product would take several years to roll out. It’s also worth noting, of course, that — despite being a potential alternative to condoms — the approach wouldn’t protect against sexually transmitted diseases.

Okay, you can uncross your legs now!

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Forget smartwatches; this smart bed could soon help keep you safe from being a fall risk
Who needs another wearable when your mattress could help spot fall risks?
Bed

Soon, a mattress protector may be more than a bed cover. Australian medtech company Sleeptite and researchers at RMIT University have received a US patent for FlexiSense, a smart bedding technology that tracks body position and posture to help caregivers identify when older residents may be at risk of falling.

The technology is being developed for Sleeptite’s in-bed monitoring system, REMi, and was recently on display at The MedTech Conference in Boston. A peer-reviewed study in Flexible and Printed Electronics says the sensors can also be made at scale without sacrificing performance or durability.

Read more
Anthropic’s sensitive internal data was exposed, and AI helped make it happen
Even the company behind Claude isn't immune to AI-powered security threats, as researchers discovered some worrying vulnerabilities.
Claude Anthropic Featured

AI companies spend enormous amounts of time convincing us their technology is safe and secure. But what happens when those same companies become targets of increasingly sophisticated AI-powered attacks? Anthropic, the company behind Claude, is now facing that question. According to a Washington Post report, cybersecurity startup Cathedral discovered vulnerabilities that let its researchers access sensitive information in Anthropic's internal systems.

The researchers used AI agents to identify potential entry points in less than 12 hours. Interestingly, they didn't need to crack Claude itself. Instead, they exploited weaknesses in third-party business applications that Anthropic uses for everyday operations. Anthropic's security testing program disclosed the findings, which allows outside researchers to identify and report vulnerabilities.

Read more
A new startup wants to fix the military’s working-dog shortage with cloning and gene editing
Promising pitch, plenty of unanswered questions about the dogs.
a new startup wants to fix the militarys working dog shortage with cloning and gene editing warhound featured image

Military working dogs charge into places the rest of us would flee. So, I understand why anyone would want to breed tougher, healthier dogs for the job.

Warhound, a new startup from Colossal Biosciences co-founder Ben Lamm and Anduril co-founder Palmer Luckey, has stepped out of stealth with $200 million to clone and gene-edit working dogs for American troops, police departments, and emergency services (via TechCrunch).

Read more